New Zealand markets close in 16 minutes
  • NZX 50

    11,123.04
    -50.33 (-0.45%)
     
  • NZD/USD

    0.6466
    -0.0012 (-0.19%)
     
  • NZD/EUR

    0.6044
    -0.0016 (-0.27%)
     
  • ALL ORDS

    7,359.30
    -32.40 (-0.44%)
     
  • ASX 200

    7,122.80
    -32.40 (-0.45%)
     
  • OIL

    110.92
    +0.59 (+0.53%)
     
  • GOLD

    1,845.00
    -1.30 (-0.07%)
     
  • NASDAQ

    11,943.93
    +174.09 (+1.48%)
     
  • FTSE

    7,522.75
    +38.40 (+0.51%)
     
  • Dow Jones

    32,120.28
    +191.66 (+0.60%)
     
  • DAX

    14,007.93
    +88.18 (+0.63%)
     
  • Hang Seng

    20,145.80
    -25.47 (-0.13%)
     
  • NIKKEI 225

    26,671.89
    -5.91 (-0.02%)
     
  • NZD/JPY

    82.3370
    -0.0540 (-0.07%)
     

Pfizer CEO sees annual COVID vaccine v. boosters

In an interview with Israel's N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.

"This will not be a good scenario. What I'm hoping (is) that we will have a vaccine that you will have to do once a year," Bourla said.

"So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn't forget the other variants and that could be a solution," Bourla said.

Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting